Gene expression profiles in BCPAP cells treated with BRAF inhibitors

ABSTRACT: We performed gene expression profiling in the human papillary thyroid carcinoma (PTC) derived cell line BCPAP harboring BRAFV600E mutation following the treatment with BRAF selective inhibitors.

ORGANISM(S): Homo sapiens

PROVIDER: GSE171483 | GEO | 2021/07/13

REPOSITORIES: GEO